Target Results
Together we can achieve our vision by eliminating HCV in Saudi Arabia by 2030. Together we can head to a brighter future by saving patient lives & resources. For more details about the benefits of achieving elimination vision, please check the following info
[~90%]
Reduction in HCV new cases1,2
[~3000]
Deaths to be avoided1,2
[10 Billion]
Saudi Riyals Costs savings1,2
[260]
Fewer cases of Hepatocellular Carcinoma1,2
[7800]
Fewer cases of HCV-associated Cirrhosis1,2
[440]
Fewer cases of Decompensated Cirrhosis1,2
What could be done to help?
Explore Supporting ResourcesReferences:
1. Aljumah AA, Abaalkhail F, et al. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Saudi J Gastroenterol 2016;22:269‑81 2. Altraif I. Can hepatitis C virus be eliminated by 2030? Saudi Arabia as an example. Saudi Medical Journal. 2018;39(8):842-845. 3. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. 4. Douglass CH, et al. BMC Med. 2018;16:175. doi:10.1186/ s12916-018-1162-z 5. Reau N, et al. Hepatol Commun. 2017;1:439–452. doi:10.1002/hep4.1049 6. Vietri J, et al. BMC Gastroenterol. 2013;13:16. doi:10.1186/1471-230X-13-16 7. Ghany MG, Strader DB, ThoHowlader N, et al. SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.mas DL, et al. Hepatology. 2009;49(4):1335–1374. EMCDDA Insights. Hepatitis C among drug users in Europe. 2016;
Approval Code: ABBV-SA-00012-MC
Copyright © 2021 AbbVie Inc. North Chicago, Illinois, U.S.A.